STOCK TITAN

Xtant Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Xtant Medical Holdings, Inc. (NYSE American: XTNT) announced that CEO Sean Browne will present at the H.C. Wainwright 23rd Annual Global Investment Conference, scheduled for September 13-15, 2021. A pre-recorded presentation will be available on the company's website starting September 13, 2021, at 7:00 AM Eastern Time and will remain accessible for 90 days. Xtant Medical focuses on developing and commercializing spinal implant systems and orthobiologics for spinal fusion.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – XTNT

-2.42%
-2.42% Session move

In the trading session that priced this news, XTNT declined 2.42%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BELGRADE, Mont., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13 - 15, 2021.

A pre-recorded presentation will be available on the Investors section of the Company’s website at www.xtantmedical.com, or by clicking here, beginning on Monday, September 13, 2021 at 7:00 AM Eastern Time. The presentation will be accessible for 90 days.

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Investor Relations Contact

David Carey
Lazar FINN
Ph: 212-867-1762
Email: david.carey@finnpartners.com

126030756.2


FAQ

When will Xtant Medical Holdings present at the H.C. Wainwright conference?

Xtant Medical Holdings will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021.

Where can I find the Xtant Medical Holdings presentation?

The pre-recorded presentation by Xtant Medical Holdings will be available on their website starting September 13, 2021.

How long will the Xtant Medical Holdings presentation be available?

The presentation will be accessible for 90 days after it goes live on September 13, 2021.

What is Xtant Medical Holdings focused on?

Xtant Medical Holdings specializes in developing surgical solutions and spinal implant systems for treating spinal disorders.

Who is the CEO of Xtant Medical Holdings?

Sean Browne is the Chief Executive Officer of Xtant Medical Holdings.